508869 Stock Overview Engages in the provision of healthcare services in India and internationally. More details
Rewards Risk Analysis No risks detected for 508869 from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Apollo Hospitals Enterprise Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Apollo Hospitals Enterprise Historical stock prices Current Share Price ₹7,242.00 52 Week High ₹7,545.10 52 Week Low ₹5,618.30 Beta 0.63 1 Month Change 2.10% 3 Month Change 1.09% 1 Year Change 27.50% 3 Year Change 45.49% 5 Year Change 407.53% Change since IPO 5,693.60%
Recent News & Updates
Price target increased by 7.6% to ₹7,848 Nov 12
Second quarter 2025 earnings: EPS and revenues exceed analyst expectations Nov 07
Apollo Hospitals Enterprise Limited to Report Q2, 2025 Results on Nov 06, 2024 Oct 15
Upcoming dividend of ₹10.00 per share Aug 09
Apollo Hospitals Enterprise Limited, Annual General Meeting, Aug 30, 2024 Aug 05
Insufficient new directors Aug 01 See more updates
Price target increased by 7.6% to ₹7,848 Nov 12
Second quarter 2025 earnings: EPS and revenues exceed analyst expectations Nov 07
Apollo Hospitals Enterprise Limited to Report Q2, 2025 Results on Nov 06, 2024 Oct 15
Upcoming dividend of ₹10.00 per share Aug 09
Apollo Hospitals Enterprise Limited, Annual General Meeting, Aug 30, 2024 Aug 05
Insufficient new directors Aug 01
Apollo Hospitals Enterprise Limited to Report Q1, 2025 Results on Aug 13, 2024 Jul 31 Apollo Hospitals Enterprise Limited Recommends Final Dividend for the Fiscal Year 2023-24
Apollo Hospitals Enterprise Limited to Report Q4, 2024 Results on May 30, 2024 May 05
Advent International Reportedly Queues Up for A Stake in Apollo 24/7 Apr 27
Apollo Hospitals Enterprise Limited Announces Term Completion of Vinayak Chatterjee as Independent Director and Reconstitution of Committees Apr 02
Apollo Hospitals Announces Management Changes Mar 22
Upcoming dividend of ₹6.00 per share at 0.3% yield Feb 13
Price target increased by 9.7% to ₹6,714 Feb 12
Dividend of ₹6.00 announced Feb 10
Third quarter 2024 earnings: EPS misses analyst expectations Feb 09
Apollo Hospitals Enterprise Limited Declares Interim Dividend for the Financial Year Ending 31st March 2024, Payable on or Before 6th March 2024 Feb 08
Apollo Hospitals Enterprise Limited to Report Q3, 2024 Results on Feb 08, 2024 Jan 18
Second quarter 2024 earnings: EPS misses analyst expectations Nov 10
Apollo Hospitals Enterprise Limited to Report Q2, 2024 Results on Nov 09, 2023 Oct 28
Apollo Hospitals Enterprise Limited Appoints Madhu Sasidhar as Chief Strategy Officer of the Company W.E.F. 1St October, 2023 Sep 20
New minor risk - Financial position Aug 13
Upcoming dividend of ₹9.00 per share at 0.4% yield Aug 11
Full year 2023 earnings: EPS misses analyst expectations Aug 08
Apollo Hospitals Plans Digital Arm Stake Sale Jun 02 Apollo Hospitals Enterprise Limited, Annual General Meeting, Aug 28, 2023
Full year 2023 earnings: EPS misses analyst expectations May 31
Apollo Hospitals Enterprise Limited to Report Q4, 2023 Results on May 30, 2023 May 13
Upcoming dividend of ₹6.00 per share at 0.3% yield Feb 17
Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Feb 16 Apollo Hospitals Enterprise Limited to Report Q3, 2023 Results on Feb 14, 2023 Feb 01
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 16
First half 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 11
Apollo Hospitals Enterprise Limited to Report Q2, 2023 Results on Nov 10, 2022 Oct 15
Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) agreed to acquire 60% stake in Kerala First Health Services Pvt. Ltd. for INR 263.7 million. Oct 06
Upcoming dividend of ₹11.75 per share Aug 11
Full year 2022 earnings: EPS exceeds analyst expectations Aug 06
Apollo Hospitals Enterprise Limited to Report Q1, 2023 Results on Aug 11, 2022 Jul 28 Apollo Hospitals Enterprise Limited Recommends Dividend for the Financial Year Ended 31st March 2022, payable on or before 6th September 2022
MD & Executive Director recently bought ₹9.5m worth of stock Jun 15
Adani, Apollo Reportedly Explore Bids for Majority Stake in Metropolis Jun 07
Price target decreased to ₹4,972 May 27 Apollo Hospitals Enterprise Limited Recommends Dividend for the Financial Year Ended 31 March 2022
Amazon, Flipkart Reportedly in Talks to Buy Stake in Metropolis Healthcare May 21
Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) acquired Junction Mall for INR 1.7 billion. Mar 30
Third quarter 2022 earnings: EPS misses analyst expectations Feb 13
Apollo Hospitals Enterprise Limited to Report Q3, 2022 Results on Feb 11, 2022 Feb 11
MD & Executive Director recently sold ₹3.6b worth of stock Dec 18
Investor sentiment improved over the past week Nov 19
Price target increased to ₹5,205 Nov 16
Second quarter 2022 earnings released: EPS ₹17.24 (vs ₹4.33 in 2Q 2021) Nov 13
Investor sentiment improved over the past week Aug 20
Price target increased to ₹4,259 Aug 16
Upcoming dividend of ₹3.00 per share Aug 11
Full year 2021 earnings released: EPS ₹10.74 (vs ₹32.70 in FY 2020) Aug 11
SoftBank Reportedly Eyes Stake in Apollo Hospitals’ Pharmacy Arm Jul 14
Full year 2021 earnings released: EPS ₹10.74 (vs ₹32.70 in FY 2020) Jun 26
Price target increased to ₹3,453 Jun 25
Non-Executive Independent Director has left the company Apr 07
New 90-day high: ₹3,091 Feb 15
Price target raised to ₹2,764 Feb 15
Apollo Hospitals Enterprise Limited to Report Q3, 2021 Results on Feb 12, 2021 Jan 28
Apollo Hospitals Enterprise Limited has completed a Follow-on Equity Offering in the amount of INR 11.699999 billion. Jan 25
New 90-day high: ₹2,687 Jan 25
New 90-day high: ₹2,509 Jan 05
New 90-day high: ₹2,283 Nov 16
Price target raised to ₹2,320 Nov 13
Second quarter 2021 earnings released: EPS ₹4.33 Nov 13
Revenue and earnings beat expectations Nov 13
Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) signed a definitive agreement share purchase agreement to acquire remaining 50% stake in Apollo Gleneagles Hospital Limited from Gleneagles Development Pte Ltd for INR 4.1 billion. Nov 12
Apollo Hospitals Enterprise Limited to Report Q2, 2021 Results on Nov 11, 2020 Nov 03
Price target raised to ₹2,051 Oct 19
New 90-day high: ₹2,173 Oct 07 Apollo Hospitals Enterprise Limited announced that it expects to receive $20 million in funding from International Finance Corporation
Price target raised to ₹1,845 Sep 19
New 90-day high: ₹1,829 Sep 18
First quarter earnings released Sep 16
Upcoming Dividend of ₹2.75 Per Share Sep 10
Full year earnings released - EPS ₹32.70 Sep 04
Apollo Hospitals Enterprise Limited to Report Q1, 2021 Results on Sep 14, 2020 Sep 02
New 90-day high - ₹1,744 Aug 07 Shareholder Returns 508869 IN Healthcare IN Market 7D 0.08% -2.1% -3.2% 1Y 27.5% 39.4% 18.7%
See full shareholder returns
Return vs Market: 508869 exceeded the Indian Market which returned 18.7% over the past year.
Price Volatility Is 508869's price volatile compared to industry and market? 508869 volatility 508869 Average Weekly Movement 3.5% Healthcare Industry Average Movement 5.5% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 508869 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 508869's weekly volatility (3%) has been stable over the past year.
About the Company Apollo Hospitals Enterprise Limited, together with its subsidiaries, engages in the provision of healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company’s healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities.
Show more Apollo Hospitals Enterprise Limited Fundamentals Summary How do Apollo Hospitals Enterprise's earnings and revenue compare to its market cap? 508869 fundamental statistics Market cap ₹1.04t Earnings (TTM ) ₹11.88b Revenue (TTM ) ₹204.69b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 508869 income statement (TTM ) Revenue ₹204.69b Cost of Revenue ₹133.66b Gross Profit ₹71.03b Other Expenses ₹59.16b Earnings ₹11.88b
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 82.60 Gross Margin 34.70% Net Profit Margin 5.80% Debt/Equity Ratio 61.3%
How did 508869 perform over the long term?
See historical performance and comparison Dividends
0.2% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/25 22:38 End of Day Share Price 2024/12/24 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Apollo Hospitals Enterprise Limited is covered by 55 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Prashant Nair Ambit Capital Nitin Bhasin Ambit Capital null null Anand Rathi Shares and Stock Brokers Limited
Show 52 more analysts 
